M42 is an Abu Dhabi-based, global tech-enabled health company. It combines G42 Healthcare’s unique medical and data-centric technologies with Mubadala Health’s world-class patient services and state-of-the-art facilities to provide the highest level of personalized, precise, and preventative care.

Operating at the forefront of medical advancement, M42 is set to transform the way care is delivered, bridging the gap between the latest healthtech advancements and the clinical outcomes patients receive.

The company is seeking to transform lives through innovative clinical solutions that can solve the world’s most critical health and diagnostic challenges.

By harnessing innovative solutions, unique medical and data-centric technologies, including genomics and AI, M42 is transforming the traditional healthcare ecosystem and delivering the highest level of precise, patient-centric, and preventative care.

At PureHealth, we believe that living longer and healthier is not a challenge that needs to be overcome, but an ambition, a goal, and a purpose that needs to be realised. Which is why we are on a mission to unlock time for humankind, backed by groundbreaking innovations at the forefront of healthcare.

We are the largest integrated healthcare network in the Middle East, with a cross-category ecosystem that challenges lifespans and reimagines health spans. With 100+ hospitals, 300+ clinics, multiple diagnostic centres, health insurance solutions, pharmacies, health tech, procurement, investments and more, PureHealth is carving a new path for the healthcare sector characterised by technology, innovation and its people-centric approach.

Longevity guides us as our North Star in our quest to introduce the healthcare of the future – a vision from Abu Dhabi to the world.

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

AstraZeneca is dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.

Founded in 2007 by Dr. Shamsheer Vayalil, Burjeel Holdings is one of the leading private healthcare service providers the MENA region, providing the highest standard of healthcare delivery and patient management across a network of hospitals, medical centers, pharmacies, and other services.

Burjeel Holdings is well on its way to becoming the leading voice on healthcare systems in emerging markets and beyond. The company's focus on highly complex, specialized, and personalized services puts it in a leadership position and has made it a point of referral for domestic and international patients. The company is poised to strengthen its operations further at home and abroad. With ambitious expansion plans, Burjeel Holdings is set to bring healthcare benefits and strategic value to new markets.

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. 

We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.

With the rise of new biomolecular data classes, innovative diagnostic possibilities, and at the dawn of an artificial intelligence century with unimagined new opportunities, we want to transform the perspective on health and healthcare in the UAE and beyond the region. We are a precision lifestyle medicine institute in Abu Dhabi. Our purpose is to provide precise, predictive, preventive and data-driven care and research focused on lifestyle, longevity and performance for both individuals and populations. As ambitious and impactful as our approach is, our high-level sponsors and supporters believe that a successful implementation has the potential to scale into the greater good for everyone.

Microsoft (Nasdaq “MSFT” @microsoft) creates platforms and tools powered by AI to deliver innovative solutions that meet the evolving needs of our customers. The technology company is committed to making AI available broadly and doing so responsibly, with a mission to empower every person and every organization on the planet to achieve more.

We aspire to be the premier research-intensive biopharmaceutical company. We’re at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.

For more than 130 years, we’ve brought hope to humanity through the development of important medicines and vaccines. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

Our strategy is to deliver high value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.

Our purpose is to reimagine medicine to improve and extend people's lives and our vision to become the most valued and trusted medicines company in the world.

The PHSSR is a non-profit, global collaboration between academic, non-governmental, life sciences, healthcare, and business organisations with a unified goal to improve global health by building more sustainable and resilient health systems for the future.

PHSSR member organisations include the London School of Economics, the WHO Foundation, the World Economic Forum, AstraZeneca, KPMG, Philips, the Center for Asia-Pacific Resilience and Innovation (CAPRI) and additional organisations at the regional and national levels. Each organisation brings unique capabilities and networks to this partnership and contributes in a way that leverages its strengths.

Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice.

In recognizing our endeavor to pursue a long-term perspective in all we do, Roche has been named one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the thirteenth consecutive year. This distinction also reflects our efforts to improve access to healthcare together with local partners in every country we work.

In the Middle East, Roche offers comprehensive pharmaceutical and diagnostic expertise through the relevant and appropriate channels in 14 countries: Bahrain, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Maldives, Oman, Palestine, Qatar, Saudi Arabia, Syria, United Arab Emirates, and Yemen.

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.

One of UAE’s largest hospitals, SSMC was established as part of the Abu Dhabi Economic Vision 2030 to elevate healthcare services in the Emirate. Our world-class medical destination reinforces SEHA’s vision for positioning Abu Dhabi as a global healthcare hub.

An integrated medical facility operated by Abu Dhabi Health Services Company (SEHA), the UAE’s largest healthcare network, Sheikh Shakhbout Medical City (SSMC) provides patients with:

• World-class health care and medical services
• Cutting-edge facilities, technologies and diagnostics

The medical complex is a cornerstone of Abu Dhabi’s healthcare services which are aligned with global quality and safety standards to consolidate a new meaning for excellence.

Technology Innovation Institute (TII) is the dedicated applied research pillar of Abu Dhabi’s Advanced Technology Research Council (ATRC). TII is a pioneering global research and development center that focuses on applied research and new-age technology capabilities. The Institute has 10 dedicated research centers in advanced materials, autonomous robotics, cryptography, AI and digital science, directed energy, quantum, secure systems, propulsion and space, biotechnology, and renewable and sustainable energy. By working with exceptional talent, universities, research institutions and industry partners from all over the world, TII connects an intellectual community and contributes to building an R&D ecosystem that reinforces the status of Abu Dhabi and the UAE as a global hub for innovation.

We are a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both, to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale.

At Viatris, we see healthcare not as it is, but as it should be. We act courageously and are uniquely positioned to be a source of stability in a world of evolving healthcare needs.

Viatris empowers people worldwide to live healthier at every stage of life.

We do so via:

• Access - Providing high quality, trusted medicines, regardless of geography or circumstance
• Leadership - Advancing sustainable operations and innovative solutions to improve patient health
• Partnership - Leveraging our collective expertise to connect people to products and services